Technology | Contrast Media Injectors | September 11, 2019

Company launches new injector technology and purchasing options for combined equipment upgrades with service and support

Bayer Introduces Medrad Stellant Flex CT Injection System

September 11, 2019 — Bayer announced the introduction of the Medrad Stellant Flex computed tomography (CT) injection system. Stellant Flex offers the latest CT injection technology from Bayer with a user-driven design, minimal required technologist training, and automation that drives individualized patient protocols and personalized imaging. The system also comes with flexible options for capital equipment through the TechCare program.

Clinically, the key features of the new Stellant Flex were designed to drive efficiencies, including: 

  • 150 and 200 mL syringe sizes; 

  • New beacon technology for easy visualization of fluids; 

  • Syringe size barcode identification; 

  • Lot and expiry date information; and 

  • Increased accuracy and automation of documentation with contrast barcode reader, as well as a streamlined training program.

With this new injector, Bayer said it addresses the changing U.S. healthcare environment which has seen an overall decrease in capital funding. This often results in reduced operational budgets for hospitals, creating the need for institutions to work more efficiently and economically while maintaining quality patient care. The Medrad Stellant Flex CT injection system is designed to help address these clinical and financial challenges.

Through Bayer's TechCARE program, Stellant Flex purchasing options will help institutions maximize their CT investment. The program combines Bayer's comprehensive service coverage with two hardware upgrades over the course of a three-year contract. This prevents hardware obsolescence, safeguards equipment performance and compliance, as well as helps to anticipate and avoid service interruptions.

"Upgrading to the next-generation CT injection technology with Bayer's Stellant Flex has allowed us to streamline workflow operation. The new features have reduced documentation errors, there is little training needed for our technologist to use it, and we couldn't ask for a better sized syringe to be developed," said Andrew Clark, SRMC operations supervisor and PACS administrator, Salem Regional Medical Center, Salem, Ohio. "All of the new features combined make it a robust platform that covers all of our needs." 

For more information: www.radiologysolutions.bayer.com


Related Content

News | X-Ray

July 14, 2026 — A team of crew members aboard a commercial spaceflight acquired the first diagnostic X-rays during an ...

Time July 14, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
News | Contrast Agents

June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...

Time June 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...

Time June 01, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | FDA

May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...

Time May 18, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
Subscribe Now